William Blair analyst Andy Hsieh upgraded Nektar Therapeutics (NASDAQ: NKTR) from Market Perform to Outperform.The analyst comments "Our Take and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE